In-vitro Modulation of mTOR-HIF-1α Axis by TLR7/8 Agonist (Resiquimod) in B-Chronic Lymphocytic Leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
In-vitro Modulation of mTOR-HIF-1α Axis by TLR7/8 Agonist (Resiquimod) in B-Chronic Lymphocytic Leukemia ; day:7 ; month:4 ; year:2023 ; pages:1-9
Indian journal of hematology and blood transfusion ; (7.4.2023), 1-9
- Urheber
-
Hanafy, Rana M.
Demian, Soheir R.
Abou-Shamaa, Lobna A.
Ghallab, O.
Osman, Eman M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12288-023-01649-y
- URN
-
urn:nbn:de:101:1-2023082021065575747446
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hanafy, Rana M.
- Demian, Soheir R.
- Abou-Shamaa, Lobna A.
- Ghallab, O.
- Osman, Eman M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Deoxyguanosine is a TLR7 agonist
Intratumoral immunotherapy with the TLR7/8 agonist 3M-052
The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
Migrationsverhalten von NK-Zellen nach Stimulation mit dem TLR7-Agonisten Resiquimod
Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes
Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5-fluorouracil
Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination
Hypoxia and therapeutic treatment of EV-A71 with an immune modulator TLR7 agonist in a new immunocompetent mouse model
TLR7 agonist, DSP-0509, with radiation combination therapy enhances anti-tumor activity and modulates T cell dependent immune activation
Deoxyguanosine is a TLR7 agonist
Intratumoral immunotherapy with the TLR7/8 agonist 3M-052
The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
Migrationsverhalten von NK-Zellen nach Stimulation mit dem TLR7-Agonisten Resiquimod
Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes
Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5-fluorouracil
Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination
Hypoxia and therapeutic treatment of EV-A71 with an immune modulator TLR7 agonist in a new immunocompetent mouse model
TLR7 agonist, DSP-0509, with radiation combination therapy enhances anti-tumor activity and modulates T cell dependent immune activation
Deoxyguanosine is a TLR7 agonist
Intratumoral immunotherapy with the TLR7/8 agonist 3M-052
The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
Migrationsverhalten von NK-Zellen nach Stimulation mit dem TLR7-Agonisten Resiquimod
Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes
Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5-fluorouracil
Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination
Hypoxia and therapeutic treatment of EV-A71 with an immune modulator TLR7 agonist in a new immunocompetent mouse model